RARECast
A podcast by RARECast - Thursdays
548 Episodes
-
Deriving Rare Disease Therapies from Human Plasma
Published: 10/18/2017 -
Learning to Live with Purpose
Published: 10/11/2017 -
A Mother's Race to Find a Treatment for Her Daughter's Ultra-Rare Condition
Published: 10/4/2017 -
Screening for Rare Diseases
Published: 9/27/2017 -
A Look at the Changing World of Work for People with a Chronic Illness
Published: 9/20/2017 -
Aligning Interests in Rare Disease Partnerships
Published: 9/13/2017 -
A Veteran Venture Capitalist Discusses Investing in Rare Disease Drug Development
Published: 9/6/2017 -
A Patient Group Crafts Guidelines for Working with Pharma
Published: 8/30/2017 -
Bringing Innovation to Business Models for Rare Disease Drug Development
Published: 8/23/2017 -
Rethinking Accessibility and Dependency
Published: 8/16/2017 -
How Simon Wheatcroft, Blinded by a Rare Disease, Became an Ultramarathoner
Published: 8/9/2017 -
Spark Hoping Its Luxturna Will Become First FDA-Approved Gene Therapy
Published: 8/2/2017 -
What Rare Patient-Investors Can Learn From Venture Capitalists
Published: 7/26/2017 -
Novel Effort Delivers Failed DMD Drug to Former Clinical Trial Participants
Published: 7/19/2017 -
Centogene Seeks to Deliver Diagnoses to Rare Disease Patients Early
Published: 7/12/2017 -
Albireo Advances Pipeline for Rare Liver and Gastrointestinal Diseases
Published: 7/5/2017 -
aTyr Pharma Seeks to Modulate Activity in FSHD and Other Rare Disease
Published: 6/28/2017 -
Summit Pursues A Different Approach to Treating Duchenne
Published: 6/21/2017 -
Delivering Enzyme Replacement Therapies Across the Blood-Brain Barrier
Published: 6/14/2017 -
Sangamo Advances Gene Editing Therapies for Multiple Rare Diseases into the Clinic
Published: 6/7/2017
RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.